The role of LMO2 in development and in T Cell leukemia after chromosomal translocation or retroviral insertion

Molecular Therapy

Volumn 13, Issue 1, 2006, Pages 15-25

  Nam, Chang Hoon ^a   Rabbitts, Terence H ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Angiogenesis; Chromosomal translocation; Gene therapy; Hematopoiesis; Leukemia; LMO2; Oncogene

Indexed keywords

APTAMER; CELL ANTIBODY; DNA; GENE PRODUCT; IMATINIB; LIM PROTEIN; PEPTIDE DERIVATIVE; PROTEIN LMO2; REAGENT; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE LEUKEMIA; ANGIOGENESIS; CANCER CELL; CELL FATE; CHROMOSOME TRANSLOCATION; COMBINED IMMUNODEFICIENCY; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; GENE ACTIVATION; GENE INSERTION; GENE TARGETING; GENE THERAPY; HEMATOPOIESIS; HUMAN; LEUKEMOGENESIS; MOLECULAR GENETICS; MULTIGENE FAMILY; NONHUMAN; ONCOGENE; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RETROVIRUS; REVIEW; STEM CELL; T CELL LEUKEMIA; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; GENE THERAPY; HEMATOPOIESIS; HUMANS; LEUKEMIA, T-CELL; METALLOPROTEINS; MICE; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; NEOVASCULARIZATION, PATHOLOGIC; RETROVIRIDAE; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC;

EID: 28844477987     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.09.010     Document Type: Review

References (94)

1. T. Boveri Zur Frage der Entstehung Maligner Tumoren 1914 VCH Weinheim/ New York
2. C. Stern Boveri and the early days of genetics Nature 166 1950 446
3. P.C. Nowell D.A. Hungerford A minute chromosome in human granulocytic leukemia Science 132 1960 1497-1500
4. J.D. Rowley A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinaquine fluorescence and Giemsa staining Nature 243 1973 290-293
5. P.C. Nowell J. Jensen F. Gardner Two complex translocations in chronic granulocytic leukemia involving chromosomes 22, 9, and a third chromosome Humangenetik 30 1975 13-21
6. A. de Klein et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia Nature 300 1982 765-767
7. C.R. Bartram et al. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia Nature 306 1983 277-280
8. E. Fainstein et al. A new fused transcript in Philadelphia chromosome positive acute lymphocyte leukaemia Nature 330 1987 386-389
9. A. Hermans et al. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia Cell 51 1987 33-40
10. T.H. Rabbitts Chromosomal translocations in human cancer Nature 372 1994 143-149
11. M.L. Cleary Oncogenic conversion of transcription factors by chromosomal translocations Cell 66 1991 619-622
12. T.H. Rabbitts Translocations, master genes, and differences between the origins of acute and chronic leukemias Cell 67 1991 641-644
13. T.H. Rabbitts LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes Genes Dev. 12 1998 2651-2657
14. S. Hacein-Bey-Abina et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 2003 415-419
15. T. Boehm et al. The mechanism of chromosomal translocation t(11;14) involving the T-cell receptor Cδ locus on human chromosome 14q11 and a transcribed region of chromosome 11p15 EMBO J. 7 1988 385-394
16. E.A. McGuire et al. The t(11;14) (p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein Mol. Cell. Biol. 9 1989 2124-2132
17. T. Boehm et al. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13 Proc. Natl. Acad. Sci. USA 88 1991 4367-4371
18. B. Royer-Pokora U. Loos W.-D. Ludwig TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14) (p13;q11) Oncogene 6 1991 1887-1893
19. L. Foroni et al. The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development J. Mol. Biol. 226 1992 747-761
20. G. Grutz A. Forster T.H. Rabbitts Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: A candidate for displacement by LMO proteins in T cell acute leukaemia Oncogene 17 1998 2799-2803
21. D.A. Kenny et al. Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis Proc. Natl. Acad. Sci. USA 95 1998 11257-11262
22. J. Racevskis et al. Molecular cloning of LMO4, a new human LIM domain gene Biochem. Biophys. Acta 1445 1999 148-153
23. A.T. Look Oncogenic transcription factors in the human acute leukemias Science 278 1997 1059-1065
24. R. Baer TAL1, TAL2 and LYL1: A family of basic helix-loop-helix proteins implicated in T cell acute leukaemia Semin. Cancer Biol. 4 1993 341-347
25. A.A. Ferrando A.T. Look Gene expression profiling in T-cell acute lymphoblastic leukemia Semin. Hematol. 40 2003 274-280
26. S. Hacein-Bey-Abina et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency N. Engl. J. Med. 348 2003 255-256
27. + cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial Blood 105 2005 2699-2706
28. R.M. Frederickson Report from the 2nd stem cell clonality and genotoxicity retreat Mol. Ther. 12 2005 379-383
29. U.P. Dave N.A. Jenkins N.G. Copeland Gene therapy insertional mutagenesis insights Science 303 2004 333
30. M.P. McCormack T.H. Rabbitts Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency N. Engl. J. Med. 350 2004 913-921
31. C. Baum et al. Chance or necessity? Insertional mutagenesis in gene therapy and its consequences Mol. Ther. 9 2004 9-13
32. M. Fizzotti et al. Simultaneous expression of RBTN2 and BCR-ABL oncogenes in a T-ALL with a t(11;14) (p13;q11) and a late appearing Philadelphia chromosome Leukaemia 8 1994 1124-1130
33. G.A. Neale J.E. Rehg R.M. Goorha Ectopic expression of rhombotin-2 causes selective expansion of the thymus and T-cell tumours in transgenic mice Blood 86 1995 3060-3071
34. L.R. Finger et al. A common mechanism of chromosomal translocation in T- and B-cell neoplasia Science 234 1986 982-984
35. T. Boehm A et al. cluster of chromosome 11p13 translocations found via distinct D-D and D-D-J rearrangements of the human T cell receptor δ chain gene EMBO J. 7 1988 2011-2017
36. I. Sanchez-Garcia et al. A study of chromosome 11p13 translocations involving TCRβ and TCRδ in human T cell leukaemia Oncogene 6 1991 577-582
37. A.J. Warren et al. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development Cell 78 1994 45-58
38. P.E. Mead et al. Primitive erythropoiesis in the Xenopus embryo: The synergistic role of LMO-2, SCL and GATA-binding proteins Development 128 2001 2301-2308
39. M. Gering et al. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1 Development 130 2003 6187-6199
40. Y. Yamada et al. The T cell leukaemia LIM protein Lmo2 is necessary for adult mouse haematopoiesis Proc. Natl. Acad. Sci. USA 95 1998 3890-3895
41. L. Pardanoud F. Yassine F. Dieterlen-Lievre Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny Development 105 1989 473-485
42. Y. Yamada R. Pannell T.H. Rabbitts The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis Proc. Natl. Acad. Sci. USA 97 2000 320-324
43. Y. Yamada et al. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: A new anti-angiogenesis drug target Oncogene 21 2002 1309-1315
44. V.E. Valge-Archer et al. The LIM protein RBTN2 and the bHLH protein TAL1 are present in a complex in erythroid cells Proc. Natl. Acad. Sci. USA 91 1994 8617-8621
45. I. Wadman et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukaemia EMBO J. 13 1994 4831-4839
46. I.A. Wadman et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins EMBO J. 16 1997 3145-3157
47. G. Grutz et al. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells EMBO J. 17 1998 4594-4605
48. Z. Xu et al. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation Mol. Cell. Biol. 23 2003 7585-7599
49. R.C. Larson et al. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice Oncogene 11 1995 853-862
50. R.C. Larson et al. Protein dimerisation between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice EMBO J. 15 1996 1021-1027
51. G.A. Neale J.E. Rehg R.M. Goorha Disruption of T-cell differentiation precedes T-cell tumor formation in LMO2 (rhombotin-2) transgenic mice Leukaemia 11 1997 289-290
52. A. Daser T.H. Rabbitts Extending the repertoire of the mixed lineage leukemia gene MLL in leukemogenesis Genes Dev. 18 2004 965-974
53. V. Begay-Muller S. Ansieau A. Leutz The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene FEBS Lett. 521 2002 36-38
54. S. Mao G.A. Neale R.M. Goorha T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2 Oncogene 14 1997 1531-1539
55. N. Lecointe et al. GATA- and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene Oncogene 9 1994 2623-2632
56. E. Lecuyer et al. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1 Blood 100 2002 2430-2440
57. P. Fisch et al. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes Oncogene 7 1992 2389-2397
58. E.A. McGuire et al. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma Mol. Cell. Biol. 12 1992 4186-4196
59. S. Herblot et al. SCL and LMO1 alter thymocyte differentiation: Inhibition of E2A-HEB function and pre-Tα chain expression Nat. Immunol. 1 2000 138-144
60. S. Herblot P.D. Aplan T. Hoang Gradient of E2A activity in B-cell development Mol. Cell. Biol. 22 2002 886-900
61. D.S. Chervinsky et al. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: Parallels with E2A-deficient mice Mol. Cell. Biol. 19 1999 5025-5035
62. I. Engel C. Murre The function of E- and Id proteins in lymphocyte development Nat. Rev. Immunol. 1 2001 193-199
63. Y. Zhuang P. Cheng H. Weintraub B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB Mol. Cell. Biol. 16 1996 2898-2905
64. G. Bain et al. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas Mol. Cell. Biol. 17 1997 4782-4791
65. W. Yan et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice Mol. Cell. Biol. 17 1997 7317-7327
66. M. Tremblay et al. Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL J. Biol. Chem. 278 2003 12680-12687
67. M. Bernard et al. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers Int. Immunol. 10 1998 1539-1549
68. K. Doyle et al. Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins J. Biol. Chem. 269 1994 12099-12105
69. R.J. Barndt M. Dai Y. Zhuang Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB Mol. Cell. Biol. 20 2000 6677-6685
70. Y. Ono N. Fukuhara O. Yoshie TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3 Mol. Cell. Biol. 18 1998 6939-6950
71. S. Takagi et al. Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily Int. J. Cancer 61 1995 706-715
72. Y. Ono N. Fukuhara O. Yoshie Transcriptional activity of TAL1 in the T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL J. Biol. Chem. 272 1997 4576-4581
73. P. Vyas et al. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene Development 126 1999 2799-2811
74. K.P. Anderson S.C. Crable J.B. Lingrel The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression Blood 95 2000 1652-1655
75. R. Larson et al. T cell tumours with disparate phenotypes develop with long latency in mice transgenic for rbtn2 Oncogene 9 1994 3675-3681
76. L.F. Drynan T.L. Hamilton T.H. Rabbitts T cell tumorigenesis in Lmo2-transgenic mice lacking Rag1 Oncogene 20 2001 4412-4415
77. J. Davenport G.A. Neale R. Goorha Identification of genes potentially involved in LMO2-induced leukemogenesis Leukemia 14 2000 1986-1996
78. C.O. Pabo E. Peisach R.A. Grant Design and selection of novel Cys2His2 zinc finger proteins Annu. Rev. Biochem. 70 2001 313-340
79. T.H. Rabbitts M.R. Stocks Chromosomal translocation products engender novel intracellular therapeutic technologies Nat. Med. 9 2003 383-386
80. G.J. Hannon RNA interference Nature 418 2002 244-251
81. B.J. Druker et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia N. Engl. J. Med. 344 2001 1031-1037
82. M. Visintin et al. Selection of antibodies for intracellular function using a two-hybrid in vivo system Proc. Natl. Acad. Sci. USA 96 1999 11723-11728
83. M. Visintin et al. The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies J. Mol. Biol. 317 2002 73-83
84. E. Tse et al. Intracellular antibody capture technology: Application to selection of single chain Fv recognising the BCR-ABL oncogenic protein J. Mol. Biol. 317 2002 85-94
85. B. Royer-Pokora et al. The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: The distal promoter is removed by most 11p13 translocations in acute T cell leukaemias (T-ALL) Oncogene 10 1995 1353-1360
86. J.C. Way M. Chalfie mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans Cell 54 1988 5-16
87. G. Freyd S.K. Kim H.R. Horvitz Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11 Nature 344 1990 876-879
88. O. Karlsson et al. Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a Cys-His domain Nature 344 1990 879-882
89. T.H. Rabbitts T. Boehm LIM domains Nature 346 1990 418
90. K.L. Schmeichel M.C. Beckerle The LIM domain is a modular protein-binding interface Cell 79 1994 211-219
91. J.W. Michelsen et al. The LIM motif defines a specific zinc-binding protein domain Proc. Natl. Acad. Sci. USA 90 1993 4404-4408
92. G.C. Perez-Alvarado et al. Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP Nat. Struct. Biol. 1 1994 388-398
93. H. Osada et al. Association of erythroid transcription factors: Complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1 Proc. Natl. Acad. Sci. USA 92 1995 9585-9589
94. T. Tanaka M.N. Lobato T.H. Rabbitts Single domain intracellular antibodies: A minimal fragment for direct in vivo selection of antigen-specific intrabodies J. Mol. Biol. 331 2003 1109-1120